Refractory Large B-cell Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB13915 | Axicabtagene ciloleucel | A CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma. |
DB16582 | Lisocabtagene maraleucel | A CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB13915 | Axicabtagene ciloleucel | B-lymphocyte antigen CD19 | target |
DB16582 | Lisocabtagene maraleucel | B-lymphocyte antigen CD19 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
DB13915 | Axicabtagene ciloleucel | 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Completed | 1 |
DB01073 | Fludarabine | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |